- Certain of decision to have abortion and treatment at home
- Fulfils the criteria set out in the Abortion Act 1967
- Less than 10 weeks’ gestation on the day of mifepristone administration
- At least 16 years of age
- Adult to be at home with them following the self-administration of misoprostol
- Has a working phone, in order to contact the gynaecology ward or an ambulance in an emergency
- No significant medical conditions or contraindications to medical abortion
- No symptoms or history of ectopic pregnancy (if this has not already been excluded by ultrasound scan)
- Able to understand all information given and to follow instructions for misoprostol administration
- No cause for concern regarding wellbeing at home
- Fully understands the need to confirm the success of the procedure and available for follow-up
- Agrees to GP notification (GP will be notified if unable to contact for follow-up)
Early Medical Abortion at Home (EMAH) (Guidelines)
What's new / Latest updates
04/11/2025: Updated to comply with Scottish guidance and reflect current practice.(V2)
-
- Follow up section added
14/09/2025: Guideline reviewed (V1)
Clinical Protocol for Early Medical Abortion at Home up to 10 weeks’ gestation (EMAH)
Inclusion Criteria
Contra-Indications / Caution for mifepristone / misoprostol
Please refer to the table below.
| Absolute contra-indications | Caution required in the following circumstances (discuss with senior medical staff) |
|
|
Arranging EMAH
When arranging EMAH:
- Confirm that patient is certain of decision to proceed with EMAH. Obtain consent.
- Ensure that all inclusion criteria for EMAH are met.
- Discuss and provide (or arrange provision for) contraception
- Offer STI screening (Chlamydia/Gonorrhoea self-taken swab +/- BBV screen). Self-taken swab can be performed by patient on collecting medications from Raigmore. Self-taken postal kit will be provided with medications when collecting from Belford,Broadford and Caithness Hospitals and patient will return by post.
- Arrange a telephone follow-up appointment and obtain a reliable contact number. Inform the patient that their GP will be alerted if we are unable to contact them for follow-up.
- Advise patient on signs and symptoms that should warrant attendance to hospital as an emergency.
- Advise re analgesia
- Advise patient that they should contact the clinic if they have any of the following as the procedure may not have been effective:
- If they do not bleed within 24 hours of receiving misoprostol tablets
- If they have less than 4 days of bleeding
- If they still ‘feel’ pregnant at the end of one week or have symptoms of pregnancy such as sore breasts, sickness, tummy growing, etc.
- If the low sensitivity pregnancy test is positive or ‘invalid’ at follow-up
- If the next period does not come one month after treatment
- If they remain concerned that they may still be pregnant
- If they fail to take the misoprostol as instructed
- Anti-D is not required for patients having medical management at this gestation.
Procedure
- Medications can be collected from Raigmore, Caithness General Hospital, Belford Hospital or Broadford Hospital (Medications are also prepared in the Western Isles for collection there).
- Both mifepristone and misoprostol can be taken at home.
- Patients will be advised when to take their treatment and a patient information leaflet is provided with medications. Leaflet
- Patient first takes 200mg mifepristone orally. Advise the patient that if vomiting occurs within 2 hours then she should return for mifepristone dose to be repeated with antiemetic.
- Patient to take 800micrograms of misoprostol (four tablets) 36 to 48hrs after mifepristone. This can be taken vaginally, sublingually or buccally.
- 4 hours later they should take 400micrograms of misoprostol (two tablets) vaginally, sublingually or buccally (avoid vaginal route if bleeding heavily).
- Ensure the patient has been provided with:
- Complete drug regime
- Emergency contact number
- Contact information for routine advice and queries
- Advice on how to self-administer misoprostol
- Patient information leaflet on EMAH
- Contraception of their choice
- Pregnancy test and written information on how to use it
- STI self-taken swab test, if accepted
Follow up
- Patients are advised to do a urine pregnancy test on the day of their follow-up appointment (approximately two weeks after their misoprostol).
- If positive they will be invited for an ultrasound scan in the Unintended Pregnancy Clinic.
- If the patient is not contactable for their follow-up appointment, their GP will be notified.
- At the follow up appointment, any outstanding STI screening results should be checked and patient informed.
- If the patient has a negative pregnancy test at follow up but ongoing bleeding, they should be advised:
-
- If symptoms are mild and settling, it is reasonable to observe for up to four weeks after misoprostol prior to arranging a scan.
- If any signs of infection or retained pregnancy tissue (pain/fever/offensive loss/ worsening bleeding) they should be invited in for a medical review asap with the oncall team and a pelvic scan should be arranged to check for retained pregnancy tissue.
- If the patient is unwilling to travel, then they should be sign-posted to local services (GP or local hospital) and the rationale for a review explained
- See “Readmission after termination of pregnancy guideline” for advice in this situation. Intranet https://intranet.nhsh.scot.nhs.uk/Clinical/Maternity_GynaeServices/GynaeGuidelines/Gynaecology%20Guidelines/Readmission%20After%20Termination%20of%20Pregnancy%20Gynaecology%20Protocol.pdf
Abbreviations
Anti-D: Anti-D immunoglobulin (used to prevent Rh sensitisation)
BBV: Blood Borne Virus
EMAH: Early Medical Abortion at Home
Hrs: Hours
IUCD: Intrauterine Contraceptive Device
mg: milligrams
STI: Sexually Transmitted Infection
Swab +/- BBV screen: Swab with or without Blood Borne Virus screening
Editorial Information
Last reviewed: 15/09/2025
Next review date: 05/11/2028
Author(s): Obstetrics and Gynaecology Department .
Version: 2
Approved By: TAM subgroup of the ADTC
Reviewer name(s): Dr R Lovell.
Document Id: TAM427